All Insights
Showing 25 - 36 of 238
Regulatory and compliance
The new debarment regime for UK public procurement: how contracting authorities can avoid the pitfalls
What will the Procurement Act's introduction of a new debarment list for suppliers entail for contracting authorities?
Regulatory and compliance
Direct awards get post-pandemic overhaul under the new UK Procurement Act
UK ministers have been given sweeping new powers to bypass procurement rules to 'protect life'
Regulatory and compliance
Changes to the UK public procurement regimes set to deliver digital healthcare in the NHS
The huge potential of AI and data will help to drive efficiencies, improve patient outcomes and reduce spend
Regulatory and compliance
The next milestone approaches in the UK NHS net zero supplier roadmap
From April 2024, the NHS will proportionately extend the requirement for suppliers to prepare Carbon Reduction Plans to all procurements
Life Sciences and Healthcare
Using health data for R&D and AI: will new legislation make this possible in Germany?
The new health-data bill currently debated by the German lawmakers could be adopted this year and apply from early 2024
Life Sciences and Healthcare
Digital therapeutics in Europe: what is the state of play?
The regulatory landscape varies, but the potential for the sector is immense
IT and data
How the European Court of Justice is shaping health data anonymisation
A recent ruling gives valuable legal guidance on personal data but what are the practical implications for healthcare?
Life Sciences and Healthcare
Sunshine Act: introducing a transparent healthcare system
Law no. 62 of 3 May 2022, "Provisions on the transparency of relations between companies, professionals operating in the health
Life Sciences and Healthcare
EU's 'flexible' pharma reforms likely to require fine-tuning to address uncertainties
The reduction of the regulatory data protection period and wholesale distribution changes raise some industry concern
Life Sciences and Healthcare
EU to reform rules for drug-device combinations, product information and pharmacovigilance
The proposal's eight-week consultation has allowed the sector to assess the draft legislation in these and other areas
Life Sciences and Healthcare
EU pharmaceutical reforms to overhaul marketing and manufacturing rules
A dvertising, marketing authorisation applications and imports are among the areas targeted by the draft proposals
Life Sciences and Healthcare
Polish reimbursement law changes
A bill to amend the Act on the Reimbursement of Medicines and Certain Other Acts ('the Reimbursement Bill') is pending
